Ignite Creation Date:
2024-05-06 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03660878
Status:
COMPLETED
Last Update Posted:
2020-12-07
First Post:
2018-08-31
Brief Title:
A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis
Sponsor:
Aldeyra Therapeutics Inc
Organization:
Aldeyra Therapeutics Inc
Study Overview
Official Title:
A Multi-Center Double-Masked Randomized Parallel-Group Vehicle-Controlled Methodology Development Environmental Clinical Trial With Reproxalap Ophthalmic Solutions 025 and 05 in Subjects With Seasonal Allergic Conjunctivitis
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Multi-Center Double-Masked Randomized Parallel-Group Vehicle-Controlled Methodology Development Environmental Clinical Trial with Reproxalap Ophthalmic Solutions 025 and 05 in Subjects with Seasonal Allergic Conjunctivitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None